Biologics represents one of the fastest growing segments of the healthcare sector. In last five years, over 50 biologics been approved by the Food and Drug Administration (FDA) and close to 10,000 biologics are being evaluated across different stages of development. The growing demand for biologics has consequently led to the need for development of advanced technologies for the purification of these drug substances. This need is primarily driven by the fact that biologics are sensitive to heat and other chemically driven purification treatments, which may result in degradation of the final product.
Biopharmaceutical filtration refers to the process of purification and sterilization of biological drug products without the application of heat and chemicals. A key advancement in this industry has been the introduction of novel filtration systems, such as depth filtration systems, tangential flow filtration systems, virus filtration systems and chromatography filtration systems. These systems can be applied to a wide variety of application areas due to their flexible nature. In fact, several large pharma companies have already made investments to improve their conventional filtration technologies. The primary goal behind introducing these filters is to achieve the highest possible purity and yield of the desired biological product, along with maintaining its safety and efficacy for use in human or animal health. Given the ongoing advancements in this domain, several companies have developed and launched their proprietary biopharmaceutical filtration systems for more efficient purification of biologics.
Key Market Insights
The Filtration Market (Focus on Biologics Manufacturing) - Distribution by Type of Filtration System (Depth Filters, Tangential Flow Filters, Virus Filters and Other Membrane Filters), Type of Filter (based on use) (Disposable / Single-use Filters and Reusable / Multi-use Filters), Type of Assembly (Capsules, Cartridges and Others), Company Size (Small, Mid-sized and Large) and Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World): Industry Trends and Global Forecasts, 2023-2035 report features an extensive study of the current market landscape and future opportunity for the players offering filters for biopharmaceutical use. The report answers many key questions related to this domain.
Benefits and Growing Demand for Biopharmaceutical Filtration Systems
Biopharmaceutical filtration systems are used to separate and purify biological products, such as proteins, antibodies and vaccines. These filtration systems offer several benefits over conventional systems, such as higher efficiency, enhanced product purity and higher throughput. Driven by these benefits, the demand for efficient biopharmaceutical filtration systems is anticipated to increase, resulting in lucrative opportunities for developers.
Current Market Landscape of Biopharmaceutical Filter Developers
The market landscape of biopharmaceutical filter developers features a mix of over 80 large, mid-sized and small companies, which have the required expertise to offer various biopharmaceutical filtration systems, across different scales of operation. It is worth mentioning that more than 80% of the companies have the ability to develop membrane filters. Further, the ongoing activity in this domain indicates that biopharmaceutical filtration system developers are continuously upgrading their capabilities and infrastructure to accommodate the current and anticipated future demand.
Key Drivers behind the Biopharmaceutical Filtration Market
The biopharmaceutical industry has rapidly expanded over the years, primarily driven by increasing prevalence of chronic diseases and rising demand for regenerative therapies and personalized medicines. This has, in turn, led to a subsequent escalation in demand for filtration systems for biologics. Further, the stringent government regulations and guidelines, such as Good Manufacturing Practices (GMP) and United States Pharmacopeia (USP) standards, established to ensure product safety and quality, has created a need for advanced filtration technologies. It is also worth highlighting that, adoption of single-use technologies, and development of new and advanced filtration systems, such as tangential flow filtration, chromatography filtration and virus filtration, are likely to create new opportunities in the market.
Market Size of the Biopharmaceutical Filtration Market
Driven by the rapid growth of the biopharmaceutical industry and increasing research and development activities, the future opportunities and growth associated with the filtration market for biologics is anticipated to witness a noteworthy growth in the foreseen future. Specifically, in terms of type of filter, the market is anticipated to be driven by membrane filters. Further, more than 60% of the market is anticipated to be represented by players based in North America and Europe, in the foreseen future.
Key Players in the Biopharmaceutical Filtration Market
Examples of key players engaged in this domain (which have also been captured in this report) include Asahi Kasei, Cobetter Filtration, Corning, Merck, Pall, Parker Hannifin, Sartorius and Thermo Fisher Scientific.
Scope of the Report
The study presents an in-depth analysis of the various firms / organizations that are engaged in this domain, across different segments.
The study presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain, across different geographies. Amongst other elements, the report includes:
- An executive summary of the insights captured during our research. It offers a high-level view on the current state of biopharmaceutical filtration market and its likely evolution in the mid-long term.
- A general overview of filtration systems, highlighting details on different types of filtration systems and steps involved in sterile filtration for bioprocessing. It also presents information on the factors affecting sterile filtration, advantages of biopharmaceutical filtration systems, challenges associated with biopharmaceutical filtration systems and applications of biopharmaceutical filtration. Additionally, it presents an overview of the ongoing trends and future perspectives of the biopharmaceutical filtration industry.
- A detailed assessment of the overall market landscape of companies offering biopharmaceutical filtration systems, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), location of headquarters, type of filter system / element (depth filters, tangential flow filters, virus filters and other membrane filters) and application area(s) (viral clearance, cell culture clarification, cell separation / product purification, sterilization and others). In addition, it includes information on type of filter (based on use) (disposable or single-use and reusable or multi-use), type of filter module (encapsulated), type of media material (natural components, synthetic, polypropylene or glass microfiber), type of assembly (pod, capsule, cassette, hollow fibre, and others), novel filtration systems offered (chromatography filtration and tangential flow depth filtration) and type of technique(s) used (ultrafiltration, microfiltration and nanofiltration).
- A detailed competitiveness analysis of biopharmaceutical filtration system developers based in North America, Europe and Asia-Pacific, based on supplier strength (in terms of years of experience, company size and number of filter system / element offered), product strength (considering features of depth filters, tangential flow filters, virus filters, other membrane filters, novel filtration systems, type of technique(s) used) and application areas (viral clearance, cell culture clarification, cell separation / product purification, sterilization and others).
- Tabulated profiles of key players based in North America, Europe and Asia-Pacific that are engaged in manufacturing biopharmaceutical filtration systems (shortlisted based on company size and availability of financial information). Each profile includes a brief overview of the company, details related to its financial information (if available), product portfolio, recent developments and an informed future outlook.
- An in-depth analysis of recent developments / trends in the biopharmaceutical filtration domain, offering insights on patents that have been filed / granted for biopharmaceutical filters, since 2019, based on relevant parameters, such patent publication year, patent jurisdiction, CPC symbols, emerging focus areas, leading players (in terms of number of patents granted), patent benchmarking (in terms of CPC codes and leading players), patent characteristics and patent age. It also includes an insightful patent valuation analysis and list of leading patents based on number of citations. In addition, it provides information on recent mergers and acquisitions reported in this domain, including details on year, deal amount, regional distribution and key players (in terms of number of deals).
- A detailed analysis of global events that took place in this domain, since 2018 based on several relevant parameters, such as year of event, event platform, type of event, geography, type of filter (based on use) (single-use and reusable filters), type of filter system involved (depth filters, sterilizing grade filters, tangential flow filters, virus filters, virus filters, membrane filters and others), type of process(es) involved (upstream bioprocessing and downstream bioprocessing), most active organizers (in terms of number of events) and application area(s) (type of biologic involved), as well as prominent players.
One of the key objectives of the report was to estimate the current opportunity and the future growth potential of the biopharmaceutical filtration market over the coming years. We have provided informed estimates on the likely evolution of the market for the period, 2023-2035. Our year-wise projections of the current and forecasted opportunity have been further segmented based on relevant parameters, such as type of filter system / element (depth filters, tangential flow filters, virus filters and other membrane filters), type of filter (based on use) (disposable / single-use filters and reusable / multi-use filters), type of assembly (capsules, cartridges and others), company size (small, mid-sized and large) and key geographical regions (North America, Europe, Asia-Pacific and Rest of the World). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.
Frequently Asked Questions
Question 1: What is biopharmaceutical filtration?
Answer: Filtration is a critical step in the production of biopharmaceuticals, as it involves the separation of biological materials from the culture media, cell debris and other impurities.
Question 2: What are the different types of filtration systems used in biomanufacturing?
Answer: The various types of filtration systems used in biomanufacturing processes include depth filtration systems, tangential flow filtration systems, virus filtration systems, other membrane filtration systems and chromatography filtration systems.
Question 3: What are the limitations of conventional filter systems?
Answer: The key concerns related to conventional filter systems include limited filtration capacity, need for frequent maintenance, risk of clogging, and limited lifespan. In addition, conventional filters were not very effective in removing certain types of contaminants, such as dissolved minerals, bacteria, viruses or chemicals.
Question 4: How many companies offer filtration systems for biopharmaceutical purposes?
Answer: Presently, more than 80 companies are involved in the development of depth filters, tangential flow filters, virus filters and other membrane filters.
Question 5: How many patents, related to biopharmaceutical filtration, have been filed / granted in the last few years?
Answer: Close to 130 patents have been filed / granted related to biopharmaceutical filtration, in the last few years. It is worth mentioning that most of the patents have been filed by industry players and are focused on virus removal and protein recovery.
Question 6: What are the key trends in the biopharmaceutical filtration market?
Answer: Companies involved in this domain have made significant investments to expand their existing capabilities through the incorporation of advanced methods, technologies and platforms, in order to accommodate the current and anticipated demand for filtration systems. Further, these companies have actively participated in various conferences, meetings, seminars, exhibitions and webinars in order to present their ideas and innovative products / technologies to a wider audience.
Question 7: Which segment, in terms of type of product, is likely to have the largest share in the biopharmaceutical filtration market?
Answer: Presently, membrane filters dominate the biopharmaceutical filtration market. This can be attributed to the fact that these are widely used in biopharmaceutical manufacturing for sterile filtration and virus filtration due to their high efficiency, durability and versatility.
Question 8: How is the biopharmaceutical filtration market likely to evolve in the coming years?
Answer: The biopharmaceutical filtration market is projected to grow at a CAGR of ~10% in the coming years.
Table of Contents
1. PREFACE
1.1. Chapter Overview
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Filtration Systems
3.3. Types of Filtration Systems
3.4. Steps for Sterile Filtration for Bioprocessing
3.5. Factors Affecting Sterile Filtration
3.6. Advantages of Biopharmaceutical Filtration Systems
3.7. Challenges Associated with Biopharmaceutical Filtration Systems
3.8. Applications of Biopharmaceutical Filtration Systems
3.9. Conclusion
4. BIOPHARMACEUTICAL FILTRATION: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. List of Biopharmaceutical Filtration System Developers
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters (Region and Country-wise)
4.2.4. Analysis by Company size and Location of Headquarters
4.2.5. Analysis by Type of Filter System / Element
4.2.5.1. Depth Filtration Systems
4.2.5.1.1. Analysis by Type of Filter (based on use)
4.2.5.1.2. Analysis by Type of Media Material
4.2.5.1.3. Analysis by Type of Assembly
4.2.5.2. Tangential Flow Filtration / Crossflow Filtration Systems
4.2.5.2.1. Analysis by Type of Tangential Flow Filter (based on approach)
4.2.5.2.2. Analysis by Type of Filter (based on use)
4.2.5.2.3. Analysis by Type of Assembly
4.2.5.2.4. Analysis by Application Area(s)
4.2.5.3. Virus Filtration Systems
4.2.5.3.1. Analysis by Type of Product
4.2.5.3.2. Analysis by Application Area(s)
4.2.5.4. Other Membrane Filtration Systems
4.2.5.4.1. Analysis by Type of Filter (based on use)
4.2.5.4.2. Analysis by Type of Assembly
4.2.5.4.3. Analysis by Application Area(s)
4.2.6. Analysis by Novel Filtration Systems
4.2.7. Analysis by Type of Techniques(s) Used
4.2.8. Analysis by Application Area(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Methodology and Key Parameters
5.3. Biopharmaceutical Filtration System Developers: Company Competitiveness
5.3.1. Players Headquartered in North America
5.3.2. Players Headquartered in Europe
5.3.3. Players Headquartered in Asia-Pacific and Rest of the World
6. DEVELOPERS HEADQUARTERED IN NORTH AMERICA: COMPANY PROFILES
6.1. Chapter Overview
6.2. Corning
6.2.1. Company Overview
6.2.2. Financial Information
6.2.3. Product Portfolio
6.2.4. Recent Developments and Future Outlook
6.3. Pall Corporation
6.3.1. Company Overview
6.3.2. Financial Information
6.3.3. Product Portfolio
6.3.4. Recent Developments and Future Outlook
6.4. Parker Hannifin
6.4.1. Company Overview
6.4.2. Financial Information
6.4.3. Product Portfolio
6.4.4. Recent Developments and Future Outlook
6.5. Thermo Fisher Scientific
6.5.1. Company Overview
6.5.2. Financial Information
6.5.3. Product Portfolio
6.5.4. Recent Developments and Future Outlook
7. DEVELOPERS HEADQUARTERED IN EUROPE AND ASIA-PACIFIC: COMPANY PROFILES
7.1. Chapter Overview
7.2. Merck
7.2.1. Company Overview
7.2.2. Financial Information
7.2.3. Product Portfolio
7.2.4. Recent Developments and Future Outlook
7.3. Sartorius
7.3.1. Company Overview
7.3.2. Financial Information
7.3.3. Product Portfolio
7.3.4. Recent Developments and Future Outlook
7.4. Asahi Kasei
7.4.1. Company Overview
7.4.2. Financial Information
7.4.3. Product Portfolio
7.4.4. Recent Developments and Future Outlook
7.5. Cobetter Filtration
7.5.1. Company Overview
7.5.2. Product Portfolio
7.5.3. Recent Developments and Future Outlook
8. RECENT DEVELOPMENTS
8.1. Chapter Overview
8.2. Biopharmaceutical Filtration: Patent Analysis
8.2.1. Scope and Methodology
8.2.1.1. Analysis by Patent Publication Year
8.2.1.2. Analysis by Patent Jurisdiction
8.2.1.3. Analysis by CPC Symbols
8.2.1.4. Analysis by Emerging Focus Areas (Word Cloud)
8.2.1.5. Analysis by Type of Organization
8.2.1.6. Leading Industry Players: Analysis by Number of Patents
8.2.1.7. Leading Non-Industry Players: Analysis by Number of Patents
8.2.2. Biopharmaceutical Filtration: Patent Benchmarking Analysis
8.2.3. Analysis by Patent Characteristics
8.2.4. Biopharmaceutical Filtration: Patent Valuation Analysis
8.2.5. Analysis by Patent Age
8.2.6. Leading Patents: Analysis by Number of Citations
8.3 Biopharmaceutical Filtration: Mergers and Acquisitions
8.3.1. List of Mergers and Acquisitions
8.3.2. Cumulative Year-wise Distribution of Mergers and Acquisitions
8.3.3. Analysis by Deal Amount
8.3.4. Region Analysis
8.3.4.1. Intercontinental and Intracontinental Deals
8.3.5. Key Players: Analysis by Number of Deals
8.4. Concluding Remarks
9. GLOBAL EVENTS ANALYSIS
9.1. Chapter Overview
9.2. List of Global Events
9.2.1. Analysis by Year of Event
9.2.2. Analysis by Event Platform
9.2.3. Analysis by Type of Event
9.2.4. Analysis by Geography
9.2.5. Leading Event Organizers: Analysis by Number of Events
9.2.6. Analysis by Type of Filter (based on use) Involved
9.2.7. Analysis by Type of Filter System Involved
9.2.8. Analysis by Type of Process(es) Involved
9.2.9. Analysis by Application Area(s)
9.3. Concluding Remarks
10. MARKET FORECAST
10.1. Chapter Overview
10.2. Key Assumptions and Methodology
10.3. Biopharmaceutical Filtration Market, 2023-2035
10.3.1. Biopharmaceutical Filtration Market: Analysis by Type of Filter System, 2023 and 2035
10.3.1.1. Biopharmaceutical Filtration Market for Depth Filters, 2023-2035
10.3.1.2. Biopharmaceutical Filtration Market for Tangential Flow Filters, 2023-2035
10.3.1.3. Biopharmaceutical Filtration Market for Virus Filters, 2023-2035
10.3.1.4. Biopharmaceutical Filtration for Other Membrane Filters, 2023-2035
10.3.2. Biopharmaceutical Filtration Market: Analysis by Type of Filter (based on use), 2023 and 2035
10.3.2.1. Biopharmaceutical Filtration Market for Disposable / Single-use Filters, 2023-2035
10.3.2.2. Biopharmaceutical Filtration Market for Reusable / Multi-use Filters, 2023-2035
10.3.3. Biopharmaceutical Filtration Market: Analysis by Type of Assembly, 2023 and 2035
10.3.3.1. Biopharmaceutical Filtration Market for Capsule Filters, 2023-2035
10.3.3.2. Biopharmaceutical Filtration Market for Cartridge Filters, 2023-2035
10.3.3.3. Biopharmaceutical Filtration Market for Other Filters, 2023-2035
10.3.3. Biopharmaceutical Filtration Market: Distribution by Company Size, 2023 and 2035
10.3.3.1. Biopharmaceutical Filtration Market for Mid-sized and Small Companies, 2023-2035
10.3.3.3. Biopharmaceutical Filtration Market for Large Companies, 2023-2035
10.3.4. Biopharmaceutical Filtration Market: Analysis by Key Geographical Regions, 2023 and 2035
10.3.4.1. Biopharmaceutical Filtration Market in North America, 2023-2035
10.3.4.1.1. Biopharmaceutical Filtration Market in North America: Analysis by Type of Filter System, 2023-2035
10.3.4.1.2. Biopharmaceutical Filtration Market in North America: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.1.3. Biopharmaceutical Filtration Market in North America: Analysis by Type of Assembly, 2023-2035
10.3.4.1.4. Biopharmaceutical Filtration Market in North America: Analysis by Company Size, 2023-2035
10.3.4.2. Biopharmaceutical Filtration Market in Europe, 2023-2035
10.3.4.2.1. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Filter System, 2023-2035
10.3.4.2.2. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.2.3. Biopharmaceutical Filtration Market in Europe: Analysis by Type of Assembly, 2023-2035
10.3.4.2.4. Biopharmaceutical Filtration Market in Europe: Analysis by Company Size, 2023-2035
10.3.4.3. Biopharmaceutical Filtration Market in Asia-Pacific, 2023-2035
10.3.4.3.1. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Filter System, 2023-2035
10.3.4.3.2. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Filter (based on use), 2023-2035
10.3.4.3.3. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Type of Assembly, 2023-2035
10.3.4.3.4. Biopharmaceutical Filtration Market in Asia-Pacific: Analysis by Company Size, 2023-2035
10.3.4.4. Biopharmaceutical Filtration Market in Rest of the World, 2023-2035
10.3.4.4.1. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Filter System, 2023-2035
10.3.4.4.2. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Filter (based on use) , 2023-2035
10.3.4.4.3. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Type of Assembly, 2023-2035
10.3.4.4.4. Biopharmaceutical Filtration Market in Rest of the World: Analysis by Company Size, 2023-2035
11. CONCLUSION
12. EXECUTIVE INSIGHTS
13. APPENDIX 1: TABULATED DATA
14. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
List Of Figures
Figure 2.1. Executive Summary: Current Market Landscape
Figure 2.2. Executive Summary: Recent Developments
Figure 2.3. Executive Summary: Global Events Analysis
Figure 2.4. Executive Summary: Market Sizing and Opportunity Analysis
Figure 3.1. Types of Filtration Systems
Figure 3.2. Process of Upstream and Downstream Sterilization
Figure 3.3. Factors Affecting Efficiency of Sterile Filtration and Particle Retention
Figure 3.4. Advantages of Biopharmaceutical Filtration Systems
Figure 3.5. Applications of Biopharmaceutical Filtration Systems
Figure 4.1. Biopharmaceutical Filtration System Developers: Distribution by Year of Establishment
Figure 4.2. Biopharmaceutical Filtration System Developers: Distribution by Company Size
Figure 4.3. Biopharmaceutical Filtration System Developers: Distribution by Location of Headquarters (Region and Country-wise)
Figure 4.4. Biopharmaceutical Filtration System Developers: Distribution by Company Size and Location of Headquarters (Region-wise)
Figure 4.5. Biopharmaceutical Filtration System Developers: Distribution by Type of Filter System / Element
Figure 4.6. Depth Filtration Systems: Distribution by Type of Filter (based on use)
Figure 4.7. Depth Filtration Systems: Distribution by Type of Media Material
Figure 4.8. Depth Filtration Systems: Distribution by Type of Assembly
Figure 4.9. Tangential Flow Filtration Systems: Distribution by Type of Tangential Flow Filter (based on approach)
Figure 4.10. Tangential Flow Filtration Systems: Distribution by Type of Filter (based on use)
Figure 4.11. Tangential Flow Filtration Systems: Distribution by Type of Assembly
Figure 4.12. Tangential Flow Filtration Systems: Distribution by Application Area(s)
Figure 4.13. Virus Filtration Systems: Distribution by Type of Product
Figure 4.14. Virus Filtration Systems: Distribution by Application Area(s)
Figure 4.15. Membrane Filtration Systems: Distribution by Type of Filter (based on use)
Figure 4.16. Membrane Filtration Systems: Distribution by Type of Assembly
Figure 4.17. Membrane Filtration Systems: Distribution by Application Area(s)
Figure 4.18. Biopharmaceutical Filtration Systems: Distribution by Type of Technique(s) Used
Figure 4.19. Biopharmaceutical Filtration Systems: Distribution by Application Area(s)
Figure 5.1. Competitiveness Analysis: Biopharmaceutical Filtration System Developers based in North America
Figure 5.2. Competitiveness Analysis: Biopharmaceutical Filtration System Developers based in Europe
Figure 5.3. Competitiveness Analysis: Biopharmaceutical Filtration System Developers based in Asia-Pacific and Rest of the World
Figure 6.1. Corning: Annual Revenues, 2018 - 2022 (USD Billion)
Figure 6.2. Danaher (parent company of Pall Corporation): Annual Revenues, 2017-9M 2022 (USD Billion)
Figure 6.3. Parker Hannifin: Annual Revenues, 2018 - FY H1 2023 (USD Billion)
Figure 6.4. Thermo Fisher Scientific: Annual Revenues, 2018 - 2022 (USD Billion)
Figure 7.1. Merck: Annual Revenues, 2018 - 2022 (EUR Billion)
Figure 7.2. Sartorius: Annual Revenues, 2018 - 2022 (EUR Billion)
Figure 7.3. Asahi Kasei: Annual Revenues, FY 2018 - FY 9M 2022 (YEN Billions)
Figure 8.1. Patent Analysis: Cumulative Distribution by Patent Publication Year, 2019-20222
Figure 8.2. Patent Analysis: Distribution by Patent Jurisdiction
Figure 8.3. Patent Analysis: Distribution by CPC Symbols
Figure 8.4. Word Cloud Analysis: Emerging Focus Areas
Figure 8.5. Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2019-2022
Figure 8.6. Leading Industry Players: Distribution by Number of Patents
Figure 8.7. Leading Non-Industry Players: Distribution by Number of Patents
Figure 8.8. Patent Benchmarking Analysis (Leading Players): Distribution by Patent Characteristics (CPC Codes)
Figure 8.9. Biopharmaceutical Filtration: Patent Valuation
Figure 8.10. Patent Analysis: Distribution by Patent Age
Figure 8.11. Leading Patents: Distribution by Number of Citations
Figure 8.12. Mergers and Acquisitions: Cumulative Year-wise Trend, 2015-2022
Figure 8.13. Mergers and Acquisitions: Distribution by Deal Amount
Figure 8.14. Mergers and Acquisitions: Distribution by Region
Figure 8.15. Mergers and Acquisitions: Intercontinental and Intracontinental Deals
Figure 8.16. Key Players: Distribution by Number of Deals
Figure 9.1. Global Events: Cumulative Year-wise Distribution, 2018-2023
Figure 9.2. Global Events: Distribution by Event Platform
Figure 9.3. Global Events: Distribution by Type of Event
Figure 9.4. Global Events: Distribution by Geography
Figure 9.5. Leading Event Organizers: Distribution by Number of Events
Figure 9.6. Global Events: Distribution by Type of Filter (based on use)
Figure 9.7. Global Events: Distribution by Type of Filter System Involved
Figure 9.8. Global Events: Distribution by Type of Process(es) Involved
Figure 9.9. Global Events: Distribution by Application Area(s)
Figure 10.1. Global Biopharmaceutical Filtration Market, 2023-2035 (USD Million)
Figure 10.2. Biopharmaceutical Filtration Market: Distribution by Type of Filter System / Element, 2023 and 2035 (USD Million)
Figure 10.3. Biopharmaceutical Filtration Market for Depth Filters, 2023-2035 (USD Million)
Figure 10.4. Biopharmaceutical Filtration Market for Tangential Flow Filters, 2023-2035 (USD Million)
Figure 10.5. Biopharmaceutical Filtration Market for Virus Filters, 2023-2035 (USD Million)
Figure 10.6. Biopharmaceutical Filtration Market for Other Membrane Filters, 2023-2035 (USD Million)
Figure 10.7. Biopharmaceutical Filtration Market: Distribution by Type of Filter (based on use), 2023 and 2035
Figure 10.8. Biopharmaceutical Filtration Market for Disposable / Single-use Filters, 2023-2035 (USD Million)
Figure 10.9. Biopharmaceutical Filtration Market for Reusable / Multi-use Filters, 2023-2035 (USD Million)
Figure 10.10. Biopharmaceutical Filtration Market: Distribution by Type of Assembly, 2023-2035 (USD Million)
Figure 10.11. Biopharmaceutical Filtration Market for Capsule Filters, 2023 and 2035 (USD Million)
Figure 10.12. Biopharmaceutical Filtration Market for Cartridge Filters, 2023-2035 (USD Million)
Figure 10.13. Biopharmaceutical Filtration Market for Other Filters, 2023-2035 (USD Million)
Figure 10.14. Biopharmaceutical Filtration Market: Distribution by Company Size (USD Million)
Figure 10.15. Biopharmaceutical Filtration Market for Mid-sized and Small Companies, 2023-2035 (USD Million)
Figure 10.16. Biopharmaceutical Filtration Market for Large Companies, 2023-2035 (USD Million)
Figure 10.17. Biopharmaceutical Filtration Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)
Figure 10.18. Biopharmaceutical Filtration Market in North America, 2023-2035 (USD Million)
Figure 10.19. Biopharmaceutical Filtration Market in North America: Distribution by Type of Filter System, 2023-2035 (USD Million)
Figure 10.20. Biopharmaceutical Filtration Market in North America: Distribution by Type of Filter (based on use), 2023-2035 (USD Million)
Figure 10.21. Biopharmaceutical Filtration Market in North America: Distribution by Type of Assembly, 2023-2035 (USD Million)
Figure 10.22. Biopharmaceutical Filtration Market in North America: Distribution by Company Size, 2023-2035 (USD Million)
Figure 10.23. Biopharmaceutical Filtration Market in Europe, 2023-2035 (USD Million)
Figure 10.24. Biopharmaceutical Filtration Market in Europe: Distribution by Type of Filter System, 2023-2035 (USD Million)
Figure 10.25. Biopharmaceutical Filtration Market in Europe: Distribution by Type of Filter (based on use), 2023-2035 (USD Million)
Figure 10.26. Biopharmaceutical Filtration Market in Europe: Distribution by Type of Assembly, 2023-2035 (USD Million)
Figure 10.27. Biopharmaceutical Filtration Market in Europe: Distribution by Company Size, 2023-2035 (USD Million)
Figure 10.28. Biopharmaceutical Filtration Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 10.29. Biopharmaceutical Filtration Market in Asia-Pacific: Distribution by Type of Filter System, 2023-2035(USD Million)
Figure 10.30. Biopharmaceutical Filtration Market in Asia-Pacific: Distribution by Type of Filter (based on use) , 2023-2035 (USD Million)
Figure 10.31. Biopharmaceutical Filtration Market in Asia-Pacific: Distribution by Type of Assembly, 2023-2035 (USD Million)
Figure 10.32. Biopharmaceutical Filtration Market in Asia-Pacific: Distribution by Company Size, 2023-2035 (USD Million)
Figure 10.33. Biopharmaceutical Filtration Market in Rest of the World, 2023-2035 (USD Million)
Figure 10.34. Biopharmaceutical Filtration Market in Rest of the World: Distribution by Type of Filter System, 2023-2035 (USD Million)
Figure 10.35. Biopharmaceutical Filtration Market in Rest of the World: Distribution by Type of Filter (based on use), 2023-2035 (USD Million)
Figure 10.36. Biopharmaceutical Filtration Market in Rest of the World: Distribution by Type of Assembly, 2023-2035 (USD Million)
Figure 10.37. Biopharmaceutical Filtration Market in Rest of the World: Distribution by Company Size, 2023-2035 (USD Million)
Figure 11.1. Concluding Remarks: Current Market Landscape
Figure 11.2. Concluding Remarks: Global Event Analysis
Figure 11.3. Concluding Remarks: Recent Developments
Figure 11.4. Concluding Remarks: Market Sizing and Opportunity Analysis
List Of Tables
Table 1.1 Filtration Market: Report Attributes / Market Segmentations
Table 4.1. Biopharmaceutical Filtration System Developers: Information on Year of Establishment, Company Size, Location of Headquarters and Type of Filter System / Element
Table 4.2. Depth Filtration Systems: Information on Type of Filter (based on use), Type of Filter Module, Type of Media Material and Type of Assembly
Table 4.3. Tangential Flow Filtration Systems: Information on Type of Tangential Flow Filter (based on approach), Type of Filter (based on use), Type of Tangential Flow Filter Assembly and Application Area(s)
Table 4.4. Virus Filtration Systems: Information on Type of Product and Application Area(s)
Table 4.5. Membrane Filtration Systems: Information on Filter (based on use), Type of Assembly and Application Area(s)
Table 4.6. Biopharmaceutical Filtration Systems: Information on Type of Technique(s) Used and Application Area(s)
Table 6.1. Biopharmaceutical Filtration System Developers in North America: List of Companies Profiled
Table 6.2. Corning: Company Snapshot
Table 6.3. Corning: Overview of Product Portfolio
Table 6.4. Pall Corporation: Company Snapshot
Table 6.5. Pall Corporation: Overview of Product Portfolio
Table 6.6. Pall Corporation: Recent Developments and Future Outlook
Table 6.7. Parker Hannifin: Company Snapshot
Table 6.8. Parker Hannifin: Overview of Product Portfolio
Table 6.9. Parker Hannifin: Recent Developments and Future Outlook
Table 6.10. Thermo Fisher Scientific: Company Snapshot
Table 6.11. Thermo Fisher Scientific: Overview of Product Portfolio
Table 7.1. Biopharmaceutical Filtration System Developers in Europe and Asia-Pacific: List of Companies Profiled
Table 7.2. Merck: Company Snapshot
Table 7.3. Merck: Overview of Product Portfolio
Table 7.4. Merck: Recent Developments and Future Outlook
Table 7.5. Sartorius: Company Snapshot
Table 7.6. Sartorius: Overview of Product Portfolio
Table 7.7. Sartorius: Recent Developments and Future Outlook
Table 7.8. Asahi Kasei: Company Snapshot
Table 7.9. Asahi Kasei: Overview of Product Portfolio
Table 7.10. Asahi Kasei: Recent Developments and Future Outlook
Table 7.11. Cobetter Filtration: Company Snapshot
Table 7.12. Cobetter Filtration: Overview of Product Portfolio
Table 7.13. Cobetter Filtration: Recent Developments and Future Outlook
Table 8.1. Patent Analysis: Top CPC Sections
Table 8.2. Patent Analysis: Top CPC Symbols
Table 8.3. Patent Analysis: Top CPC Codes
Table 8.4. Patent Analysis: Summary of Benchmarking Analysis
Table 8.5. Patent Analysis: Categorization based on Weighted Valuation Scores
Table 8.6. Patent Portfolio: List of Leading Patents (by Highest Relative Valuation)
Table 8.7. Patent Portfolio: List of Leading Patents (by Number of Citations)
Table 8.8. List of Mergers and Acquisitions
Table 9.1. Biopharmaceutical Filtration: List of Global Events, 2018-2023
Table 9.2. Global Event Analysis: Information on Type of Event Platform, Type of Filter (based on use) and Type of Filter System Involved
Table 9.3. Global Event Analysis: Information on Application Area (s) and Type of Process(es) Involved
Table 13.1. Biopharmaceutical Filtration System Developers: Distribution by Year of Establishment
Table 13.2. Biopharmaceutical Filtration System Developers: Distribution by Company Size
Table 13.3. Biopharmaceutical Filtration System Developers: Distribution by Location of Headquarters (Region and Country-wise)
Table 13.4. Biopharmaceutical Filtration System Developers: Distribution by Company Size and Location of Headquarters (Region-wise)
Table 13.5. Biopharmaceutical Filtration System Developers: Distribution by Type of Filter System / Element
Table 13.6. Depth Filtration Systems: Distribution by Type of Filter (based on use)
Table 13.7. Depth Filtration Systems: Distribution by Type of Media Material
Table 13.8. Depth Filtration Systems: Distribution by Type of Assembly
Table 13.9. Tangential Flow Filtration Systems: Distribution by Type of Tangential Flow Filter (based on approach)
Table 13.10. Tangential Flow Filtration Systems: Distribution by Type of Filter (based on use)
Table 13.11. Tangential Flow Filtration Systems: Distribution by Type of Assembly
Table 13.12. Tangential Flow Filtration Systems: Distribution by Application Area(s)
Table 13.13. Virus Filtration Systems: Distribution by Type of Product
Table 13.14. Virus Filtration Systems: Distribution by Application Area(s)
Table 13.15. Membrane Filtration Systems: Distribution by Type of Filter (based on use)
Table 13.16. Membrane Filtration Systems: Distribution by Type of Assembly
Table 13.17. Membrane Filtration Systems: Distribution by Application Area(s)
Table 13.18. Biopharmaceutical Filtration Systems: Distribution by Type of Technique(s) Used
Table 13.19. Biopharmaceutical Filtration Systems: Distribution by Application Area(s)
Table 13.20. Corning: Annual Revenues, 2018 - 2022 (USD Billion)
Table 13.21. Danaher (parent company of Pall Corporation): Annual Revenues, 2017-9M 2022 (USD Billion)
Table 13.22. Parker Hannifin: Annual Revenues, 2018 - FY H1 2023 (USD Billion)
Table 13.23. Thermo Fisher Scientific: Annual Revenues, 2018 - 2022 (USD Billion)
Table 13.24. Merck: Annual Revenues, 2018 - 2022 (EUR Billion)
Table 13.25. Sartorius: Annual Revenues, 2018 - 2022 (EUR Billion)
Table 13.26. Asahi Kasei: Annual Revenues, FY 2018 - FY 9M 2022 (YEN Billions)
Table 13.27. Patent Analysis: Cumulative Distribution by Patent Publication Year, 2019-20222
Table 13.28. Patent Analysis: Distribution by Patent Jurisdiction
Table 13.29. Patent Analysis: Distribution by CPC Symbols
Table 13.30. Word Cloud Analysis: Emerging Focus Areas
Table 13.31. Patent Analysis: Cumulative Year-wise Distribution by Type of Organization, 2019-2022
Table 13.32. Leading Industry Players: Distribution by Number of Patents
Table 13.33. Leading Non-Industry Players: Distribution by Number of Patents
Table 13.34. Patent Benchmarking Analysis (Leading Players): Distribution by Patent Characteristics (CPC Codes)
Table 13.35. Patent Analysis: Distribution by Patent Age
Table 13.36. Leading Patents: Distribution by Number of Citations
Table 13.37. Mergers and Acquisitions: Cumulative Year-wise Trend, 2015-2022
Table 13.38. Mergers and Acquisitions: Distribution by Deal Amount
Table 13.39. Mergers and Acquisitions: Distribution by Region
Table 13.40. Mergers and Acquisitions: Intercontinental and Intracontinental Deals
Table 13.41. Key Players: Distribution by Number of Deals
Table 13.42. Global Events: Cumulative Year-wise Distribution, 2018-2023
Table 13.43. Global Events: Distribution by Event Platform
Table 13.44. Global Events: Distribution by Type of Event
Table 13.45. Global Events: Distribution by Geography
Table 13.46. Leading Event Organizers: Distribution by Number of Events
Table 13.47. Global Events: Distribution by Type of Filter (based on use)
Table 13.48. Global Events: Distribution by Type of Filter System Involved
Table 13.49. Global Events: Distribution by Type of Process(es) Involved
Table 13.50. Global Events: Distribution by Application Area(s)
Table 13.51. Global Biopharmaceutical Filtration Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.52. Biopharmaceutical Filtration Market: Distribution by Type of Filter System, 2023 and 2035 (USD Million)
Table 13.53. Biopharmaceutical Filtration Market for Depth Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.54. Biopharmaceutical Filtration Market for Tangential Flow Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.55. Biopharmaceutical Filtration Market for Virus Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.56. Biopharmaceutical Filtration Market for Other Membrane Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.57. Biopharmaceutical Filtration Market: Distribution by Type of Filter (based on use), 2023 and 2035
Table 13.58. Biopharmaceutical Filtration Market for Disposable / Single-use Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.59. Biopharmaceutical Filtration Market for Reusable / Multi-use Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.60. Biopharmaceutical Filtration Market: Distribution by Type of Assembly, 2023-2035 (USD Million)
Table 13.61. Biopharmaceutical Filtration Market for Capsule Filters, Conservative, Base and Optimistic Scenario, 2023 and 2035 (USD Million)
Table 13.62. Biopharmaceutical Filtration Market for Cartridge Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.63. Biopharmaceutical Filtration Market for Other Filters, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.64. Biopharmaceutical Filtration Market: Distribution by Company Size, 2023 and 2035 (USD Million)
Table 13.65. Biopharmaceutical Filtration Market for Mid-sized and Small Companies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.66. Biopharmaceutical Filtration Market for Large Companies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.67. Biopharmaceutical Filtration Market: Distribution by Key Geographical Regions, 2023 and 2035 (USD Million)
Table 13.68. Biopharmaceutical Filtration Market in North America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.69. Biopharmaceutical Filtration Market in North America, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter System, 2023-2035 (USD Million)
Table 13.70. Biopharmaceutical Filtration Market in North America, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter (based on use), 2023-2035 (USD Million)
Table 13.71. Biopharmaceutical Filtration Market in North America, Conservative, Base and Optimistic Scenario: Distribution by Type of Assembly, 2023-2035 (USD Million)
Table 13.72. Biopharmaceutical Filtration Market in North America, Conservative, Base and Optimistic Scenario: Distribution by Company Size, 2023-2035 (USD Million)
Table 13.73. Biopharmaceutical Filtration Market in Europe, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.74. Biopharmaceutical Filtration Market in Europe, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter System, 2023-2035 (USD Million)
Table 13.75. Biopharmaceutical Filtration Market in Europe, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter (based on use), 2023-2035 (USD Million)
Table 13.76. Biopharmaceutical Filtration Market in Europe, Conservative, Base and Optimistic Scenario: Distribution by Type of Assembly, 2023-2035 (USD Million)
Table 13.77. Biopharmaceutical Filtration Market in Europe, Conservative, Base and Optimistic Scenario: Distribution by Company Size, 2023-2035 (USD Million)
Table 13.78. Biopharmaceutical Filtration Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.79. Biopharmaceutical Filtration Market in Asia-Pacific, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter System, 2023-2035(USD Million)
Table 13.80. Biopharmaceutical Filtration Market in Asia-Pacific, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter (based on use) , 2023-2035 (USD Million)
Table 13.81. Biopharmaceutical Filtration Market in Asia-Pacific, Conservative, Base and Optimistic Scenario: Distribution by Type of Assembly, 2023-2035 (USD Million)
Table 13.82. Biopharmaceutical Filtration Market in Asia-Pacific, Conservative, Base and Optimistic Scenario: Distribution by Company Size, 2023-2035 (USD Million)
Table 13.83. Biopharmaceutical Filtration Market in Rest of the World, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 13.84. Biopharmaceutical Filtration Market in Rest of the World, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter System, 2023-2035 (USD Million)
Table 13.85. Biopharmaceutical Filtration Market in Rest of the World, Conservative, Base and Optimistic Scenario: Distribution by Type of Filter (based on use), 2023-2035 (USD Million)
Table 13.86. Biopharmaceutical Filtration Market in Rest of the World, Conservative, Base and Optimistic Scenario: Distribution by Type of Assembly, 2023-2035 (USD Million)
Table 13.87. Biopharmaceutical Filtration Market in Rest of the World, Conservative, Base and Optimistic Scenario: Distribution by Company Size, 2023-2035 (USD Million)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M
- 4th Phase Water Technologies
- ABEC
- Agilitech
- Alfa Laval
- Almirall
- Amazon Filters
- American Filtration & Separations Society (AFS)
- Amgen
- Artemis Biosystems
- ARTeSYN Biosolutions (Acquired by Repligen)
- Asahi Kasei
- Automated Engineering Services
- BEA Technologies
- Becton Dickinson
- Bio - Link
- BioCon Solutions
- BIONET
- Bionova Scientific (Acquired by Asahi Kasei)
- Biotree
- Cambridge Healthtech Institute
- Cobetter Filtration
- Cole - Parmer (Acquired by Antylia Scientific)
- Corning
- Critical Process Filtration
- Cytiva
- Danaher
- Donaldson
- DrM
- Eaton
- Entegris
- ErtelAlsop
- Filtravate
- FILTROX
- GE Heathcare (Acquired by Danaher)
- GEA
- Genzyme (Acquired by Sanofi)
- GeShi Fluid (Acquired by LePure Biotech)
- Global Filter
- Gopani Product Systems
- Gore PharmBIO Products
- GPC Bio
- Graver Technologies
- Guochu Technology
- GVS
- Hangzhou Deefine Filtration Technology
- Hangzhou Guidling Technology
- Hangzhou Anow Microfiltration (Acquired by Entegris)
- Helapet
- Hollingsworth & Vose
- Hongtek Filtration
- INDA
- InnovaPrep
- International Filter Products
- International Flavors & Fragrances
- Isolere Bio (Acquired by Donaldson)
- Koch Separation Solutions
- LePure Biotech
- Lisure Science
- mdi Membrane Technologies
- Meissner Filtration Products
- Membrane Solutions
- Merck
- Metso Outotec
- Microfilt
- MMS Membrane Systems
- Murata Manufacturing
- Nantong FilterBio Membrane
- Napro Scientific
- Novasep
- Nupore Filtration Systems
- Pacira Pharmaceuticals (a subsidiary of Pacira Biosciences)
- Pall Corporation (Acquired by Danaher)
- Pall-Austar Lifesciences (Acquired by Pall Corporation)
- Parker Hannifin
- Perfect Group
- Phenomenex
- Porvair Filtration
- RephiLe Bioscience
- Repligen
- Rocker Scientific
- SABEU
- Saint-Gobain
- SANI Membranes
- Sartorius
- Schneider Electric
- Sentinel Process Systems
- Serene Filter Solution
- Simsii
- SmartfFow Technologies
- Solaris Biotech (Acquired by Donaldson)
- Spectrum Pharmaceuticals (Acquired by Repligen)
- Sterlitech
- Synder Filtration
- Sysbiotech
- TAMI Industries
- TangenX (Acquired by Repligen)
- Technofilter
- The Strainrite Companies
- Thermo Fisher Scientific
- TPP Techno Plastic Products
- Trinity Filtration Technologies
- VyCAP
- WaterSep BioSeparations (Acquired by Sartorius)
- Wisconsin Alumni Research Foundation
- YMC America
- Zhejiang ALWSCI Technologies
- Zista Education
Methodology
LOADING...
